{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:30:26Z","timestamp":1777649426500,"version":"3.51.4"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:p>Sickle cell disease (SCD) is a chronic hematologic disorder which causes progressive cerebral arteriopathy beginning in childhood. As a result, arterial ischemic stroke is a major cause of morbidity and mortality in SCD, and SCD is a leading cause of childhood stroke worldwide. Allogenic hematopoietic stem cell transplant (HSCT) may be curative for individuals with SCD. Long-term outcomes and effects are currently being studied. In this report, we describe a child with SCD who presented with arterial ischemic stroke at 6 years of age and was found to have a severe form of cerebral large vessel arteriopathy by catheter-directed angiography. The patient initially underwent revascularization surgery by indirect superficial temporal artery to middle cerebral artery bypass, and 1 year later, he underwent curative HSCT. Approximately 3 years after HSCT, repeat catheter-directed angiography revealed a striking reversal of cerebral large vessel arteriopathy. This article reveals a previously unrecognized and potentially beneficial effect of HSCT that may ameliorate cerebral large vessel arteriopathy and improve cerebrovascular health for children with SCD.<\/jats:p>","DOI":"10.1542\/peds.2023-062643","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T08:07:00Z","timestamp":1706083620000},"source":"Crossref","is-referenced-by-count":4,"title":["Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease"],"prefix":"10.1542","volume":"153","author":[{"given":"Natalie","family":"Booth","sequence":"first","affiliation":[{"name":"aCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Ngwube","sequence":"additional","affiliation":[{"name":"bCenter for Cancer and Blood Disorders"},{"name":"eDepartment of Child Health, College of Medicine, University of Arizona, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Appavu","sequence":"additional","affiliation":[{"name":"cDivisions of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Shah","sequence":"additional","affiliation":[{"name":"bCenter for Cancer and Blood Disorders"},{"name":"eDepartment of Child Health, College of Medicine, University of Arizona, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Abruzzo","sequence":"additional","affiliation":[{"name":"dRadiology, Phoenix Children\u2019s Hospital, Phoenix, Arizona"},{"name":"eDepartment of Child Health, College of Medicine, University of Arizona, Phoenix, Arizona"},{"name":"fCollege of Medicine, Mayo Clinic, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"12","key":"2024020102564028100_B1","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/pbc.25655","article-title":"contribution of sickle cell disease to the pediatric stroke burden among hospital discharges of African Americans\u2013United States, 1997\u20132012","volume":"62","author":"Baker","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2024020102564028100_B2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"2024020102564028100_B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"17","key":"2024020102564028100_B4","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2024020102564028100_B5","doi-asserted-by":"crossref","first-page":"e30336","DOI":"10.1002\/pbc.30336","article-title":"Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: results of the stroke in sickle cell revascularization surgery retrospective study","volume":"70","author":"Aldana","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2024020102564028100_B6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pbc.26022","article-title":"Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy","volume":"63","author":"Hall","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2024020102564028100_B7","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anemia in Nigeria (SPRING): a double-blind, multicenter, randomized, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"},{"issue":"8","key":"2024020102564028100_B8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"2024020102564028100_B9","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"2024020102564028100_B10","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2024020102564028100_B11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14740\/jh949","article-title":"Hematopoietic stem cell transplantation stabilizes cerebral vasculopathy in high-risk pediatric sickle cell disease patients: evidence from a referral transplant center","volume":"11","author":"Al-Jefri","year":"2022","journal-title":"J Hematol (Brossard)"},{"issue":"5","key":"2024020102564028100_B12","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1212\/WNL.0000000000004906","article-title":"The pediatric stroke outcome measure: a predictor of outcome following arterial ischemic stroke","volume":"90","author":"Cooper","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"2024020102564028100_B13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.2022016618","article-title":"Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with\u00a0sickle cell disease","volume":"141","author":"Hulbert","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2024020102564028100_B14","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1002\/ajh.25455","article-title":"Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease","volume":"94","author":"Jordan","year":"2019","journal-title":"Am J Hematol"},{"issue":"2","key":"2024020102564028100_B15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1531-8249(20010201)49:2<222::AID-ANA42>3.0.CO;2-S","article-title":"Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts","volume":"49","author":"Steen","year":"2001","journal-title":"Ann Neurol"},{"issue":"4","key":"2024020102564028100_B16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.2022018229","article-title":"Anemia and brain hypoxia","volume":"141","author":"Wood","year":"2023","journal-title":"Blood"},{"issue":"11","key":"2024020102564028100_B17","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41409-021-01365-z","article-title":"Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients","volume":"56","author":"Costa","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2024020102564028100_B18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fneur.2019.01267","article-title":"Angiographic outcomes of direct and combined bypass surgery in moyamoya disease","volume":"10","author":"Ge","year":"2019","journal-title":"Front Neurol"},{"key":"2024020102564028100_B19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2022.06.017","article-title":"Cerebral arterial growth in childhood","volume":"134","author":"Taylor","year":"2022","journal-title":"Pediatr Neurol"},{"issue":"10","key":"2024020102564028100_B20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keh301","article-title":"Hematopoietic stem cell transplantation for refractory Takayasu\u2019s arteritis","volume":"43","author":"Voltarelli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2024020102564028100_B21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10067-017-3600-2","article-title":"Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation","volume":"36","author":"Henrickson","year":"2017","journal-title":"Clin Rheumatol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062643\/1593336\/peds.2023-062643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062643\/1593336\/peds.2023-062643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T02:57:02Z","timestamp":1706756222000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/2\/e2023062643\/196463\/Reversal-of-Cerebral-Arteriopathy-Post"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,24]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-062643","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"e2023062643"}}